No Data
Redhill Biopharma Announces FDA Rare Pediatric Disease Designation For Opaganib For The Treatment Of Neuroblastoma
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
Express News | Cumberland Pharmaceuticals: Three Deaths Due to Distant Metastatic Disease Occurred in the Placebo Arm, and None Occurred in the Ifetroban Arm
Express News | Cumberland Pharmaceuticals - No Serious Adverse Events Related to Ifetroban or Placebo Identified
Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis
12 Health Care Stocks Moving In Thursday's Pre-Market Session